Cholera and COVID-19 pandemic prevention in multiple hotspot districts of Uganda: vaccine coverage, adverse events following immunization and WASH conditions survey
暂无分享,去创建一个
A. Kisakye | J. Bukenya | Godfrey Bwire | Alfred Okello | Christine Aanyu | Brenda D Nakirya | Esther Amulen | Stephen Acellam Okello | C. G. Orach | John Baptist Bwanika | Joan Badebye
[1] D. Sack,et al. Development of a Scorecard to Monitor Progress toward National Cholera Elimination: Its Application in Uganda , 2023, The American journal of tropical medicine and hygiene.
[2] F. Mirzaie,et al. Evaluation of Side Effects Associated with COVID-19 Vaccines in Pregnant Women , 2023, Medical Journal of The Islamic Republic of Iran.
[3] L. Atuhaire,et al. Factors Associated with COVID-19 Vaccine Hesitancy in Uganda: A Population-Based Cross-Sectional Survey , 2022, International journal of general medicine.
[4] Wan Yang,et al. COVID-19 pandemic dynamics in India, the SARS-CoV-2 Delta variant and implications for vaccination , 2022, Journal of the Royal Society Interface.
[5] T. Cherian,et al. Application of the Child Health and Nutrition Research Initiative (CHNRI) methodology to prioritize research to enable the implementation of Ending Cholera: A global roadmap to 2030 , 2022, PloS one.
[6] S. Rubino,et al. Alpha, Beta, Delta, Omicron, and SARS-CoV-2 Breakthrough Cases: Defining Immunological Mechanisms for Vaccine Waning and Vaccine-Variant Mismatch , 2022, Frontiers in Virology.
[7] A. Talisuna,et al. The COVID-19 pandemic in the African continent , 2022, BMC Medicine.
[8] Dong Seok Lee,et al. Adverse events following COVID-19 vaccination in South Korea between February 28 and August 21, 2021: A nationwide observational study , 2022, International Journal of Infectious Diseases.
[9] D. Sack,et al. An innovative approach in monitoring oral cholera vaccination campaign: integration of a between-round survey , 2022, BMC Public Health.
[10] Mosoka P. Fallah,et al. COVID-19 vaccine hesitancy in Africa: a call to action , 2021, The Lancet Global Health.
[11] M. M. Hasan,et al. Threats and outbreaks of cholera in Africa amidst COVID-19 pandemic: a double burden on Africa’s health systems , 2021, Tropical Medicine and Health.
[12] Wan Yang,et al. COVID-19 pandemic dynamics in India, the SARS-CoV-2 Delta variant, and implications for vaccination. , 2021, medRxiv : the preprint server for health sciences.
[13] E. Callaway. Remember Beta? New data reveal variant's deadly toll. , 2021, Nature.
[14] G. Reyes-Terán,et al. Guillain-Barré syndrome is infrequent among recipients of the BNT162b2 mRNA COVID-19 vaccine , 2021, Clinical Immunology.
[15] C. Wiysonge,et al. COVID-19 vaccine hesitancy in South Africa: A complex social phenomenon. , 2021, South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde.
[16] Yunfeng Shang,et al. Effects of Pandemic Outbreak on Economies: Evidence From Business History Context , 2021, Frontiers in Public Health.
[17] J. Clemens,et al. Licensed and Recommended Inactivated Oral CholeraVaccines: From Development to Innovative Deployment , 2021, Tropical medicine and infectious disease.
[18] G. Boivin,et al. Pandemics Throughout History , 2021, Frontiers in Microbiology.
[19] D. Sack,et al. Use of surveys to evaluate an integrated oral cholera vaccine campaign in response to a cholera outbreak in Hoima district, Uganda , 2020, BMJ Open.
[20] Justin Wong,et al. What do we know about SARS-CoV-2 transmission? A systematic review and meta-analysis of the secondary attack rate and associated risk factors , 2020, PloS one.
[21] E. McBryde,et al. Economic Consequences of the COVID-19 Outbreak: the Need for Epidemic Preparedness , 2020, Frontiers in Public Health.
[22] Feng He,et al. Coronavirus disease 2019: What we know? , 2020, Journal of medical virology.
[23] K. Yuen,et al. Clinical Characteristics of Coronavirus Disease 2019 in China , 2020, The New England journal of medicine.
[24] L. Pezzoli. Global oral cholera vaccine use, 2013-2018. , 2020, Vaccine.
[25] J. Clemens,et al. Epidemiology of cholera. , 2020, Vaccine.
[26] F. Checchi,et al. Prevention and control of cholera with household and community water, sanitation and hygiene (WASH) interventions: A scoping review of current international guidelines , 2020, PloS one.
[27] T. D. Agusomu,et al. Assessment of Water, Sanitation and Hygiene Services in Sub-Saharan Africa , 2018, European Scientific Journal ESJ.
[28] B. Gessner,et al. Oral cholera vaccine coverage during a preventive door-to-door mass vaccination campaign in Nampula, Mozambique , 2018, PloS one.
[29] D. Legros. Global Cholera Epidemiology: Opportunities to Reduce the Burden of Cholera by 2030 , 2018, The Journal of infectious diseases.
[30] Goal 6: Ensure availability and sustainable management of water and sanitation for all , 2018, The Sustainable Development Goals Report 2018.
[31] D. Sack,et al. Identifying cholera "hotspots" in Uganda: An analysis of cholera surveillance data from 2011 to 2016 , 2017, PLoS neglected tropical diseases.
[32] B. Gessner,et al. Epidemiology of cholera outbreaks and socio-economic characteristics of the communities in the fishing villages of Uganda: 2011-2015 , 2017, PLoS neglected tropical diseases.
[33] P. Reeves,et al. Origins of the current seventh cholera pandemic , 2016, Proceedings of the National Academy of Sciences.
[34] C. Orach,et al. Cross-Border Cholera Outbreaks in Sub-Saharan Africa, the Mystery behind the Silent Illness: What Needs to Be Done? , 2016, PloS one.
[35] E. Gotuzzo,et al. The greatest steps towards the discovery of Vibrio cholerae. , 2014, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.
[36] Isaac Chun-Hai Fung,et al. Cholera transmission dynamic models for public health practitioners , 2014, Emerging Themes in Epidemiology.
[37] Young Eun Kim,et al. The Burden of Cholera in Uganda , 2013, PLoS neglected tropical diseases.
[38] D. Sack. A new era in the history of cholera: the road to elimination. , 2013, International journal of epidemiology.
[39] R. Grais,et al. First Outbreak Response Using an Oral Cholera Vaccine in Africa: Vaccine Coverage, Acceptability and Surveillance of Adverse Events, Guinea, 2012 , 2013, PLoS neglected tropical diseases.
[40] Allan Donner,et al. Efficacy of a Low-Cost, Inactivated Whole-Cell Oral Cholera Vaccine: Results from 3 Years of Follow-Up of a Randomized, Controlled Trial , 2011, PLoS neglected tropical diseases.
[41] A. Blenkinsop,et al. World Health , 1957, Nature.
[42] C. Dolea,et al. World Health Organization , 1949, International Organization.
[43] Melbourne Victoria,et al. A Ministry of Health , 1917, Nature.
[44] C. Macnamara. On Cholera , 1868, The Indian medical gazette.
[45] J. Snow. On the Mode of Communication of Cholera , 1856, Edinburgh medical journal.
[46] World Health Organization,et al. Transmission of SARS-CoV-2: implications for infection prevention precautions , 2020 .
[47] Cholera vaccines: WHO position paper – August 2017. , 2017, Releve epidemiologique hebdomadaire.
[48] R. Henderson,et al. Cluster sampling to assess immunization coverage: a review of experience with a simplified sampling method. , 1982, Bulletin of the World Health Organization.